The company’s revenue from operations was up 13.8% to ₹1,302.7 crore as against ₹1,145 crore in the corresponding period of the preceding fiscal. Shares of Ajanta Pharma Limited ended at ₹2,753.65, down by ₹27.65 or 0.99% on the BSE.
The company’s revenue from operations was up 13.8% to ₹1,302.7 crore as against ₹1,145 crore in the corresponding period of the preceding fiscal. Shares of Ajanta Pharma Limited ended at ₹2,753.65, down by ₹27.65 or 0.99% on the BSE.